| Medical Mutual | Pediatric Preventive Screening | 2025-03-05 |
| Medical Mutual | Prescription Medication and Illicit Drug Testing in the Outpatient Setting | 2025-03-05 |
| Medical Mutual | Prostate Specific Antigen (PSA) Testing | 2025-03-05 |
| Medical Mutual | Salivary Hormone Testing | 2025-03-05 |
| Medical Mutual | Thyroid Disease Testing | 2025-03-05 |
| Medical Mutual | Urinary Tumor Markers for Bladder Cancer | 2025-03-05 |
| Medical Mutual | Venous and Arterial Thrombosis Risk Testing | 2025-03-05 |
| Medical Mutual | Bortezomib: Velcade® (Intravenous/Subcutaneous) | 2025-03-04 |
| Medical Mutual | Spevigo® (spesolimab) (Intravenous) | 2025-03-04 |
| Medical Mutual | Bortezomib: Velcade® (Intravenous/Subcutaneous) | 2025-03-04 |